Smooth muscle cell signal transduction: Implications of vascular biology for vascular surgeons

Journal of Vascular Surgery

Volumn 45, Issue 6 SUPPL., 2007, Pages A15-A24

  Muto, Akihito ^a   Fitzgerald, Tamara N ^a   Pimiento, Jose M ^a,b   Maloney, Stephen P ^a,b   Teso, Desarom ^a,b   Paszkowiak, Jacek J ^a,b   Westvik, Tormod S ^a   Kudo, Fabio A ^a   Nishibe, Toshiya ^c   Dardik, Alan ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST MARY S HOSPITAL   (United States)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DEATH RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; RHO FACTOR;

APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL WALL; CELL HETEROGENEITY; CELL MIGRATION; CELL PROLIFERATION; HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SURGEON; VASCULAR SURGERY;

EID: 34249306918     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.02.061     Document Type: Article

References (134)

1. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75 (1995) 487-517
2. Kockx M.M., and Knaapen M.W. The role of apoptosis in vascular disease. J Pathol 190 (2000) 267-280
3. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 340 (1999) 115-126
4. Schwartz S.M., Heimark R.L., and Majesky M.W. Developmental mechanisms underlying pathology of arteries. Physiol Rev 70 (1990) 1177-1209
5. Mitra A.K., Gangahar D.M., and Agrawal D.K. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol 84 (2006) 115-124
6. Westerband A., Mills J.L., Marek J.M., Heimark R.L., Hunter G.C., and Williams S.K. Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses. J Vasc Surg 25 (1997) 64-73
7. Hao H., Gabbiani G., and Bochaton-Piallat M.L. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 23 (2003) 1510-1520
8. Zalewski A., Shi Y., and Johnson A.G. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond?. Circ Res 91 (2002) 652-655
9. Sartore S., Chiavegato A., Faggin E., Franch R., Puato M., Ausoni S., et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res 89 (2001) 1111-1121
10. Yoshida T., and Owens G.K. Molecular determinants of vascular smooth muscle cell diversity. Circ Res 96 (2005) 280-291
11. Powell D.W., Mifflin R.C., Valentich J.D., Crowe S.E., Saada J.I., and West A.B. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277 (1999) C1-C9
12. Scott N.A., Cipolla G.D., Ross C.E., Dunn B., Martin F.H., Simonet L., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
13. Shi Y., O'Brien J.E., Fard A., Mannion J.D., Wang D., and Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94 (1996) 1655-1664
14. Shi Y., O'Brien Jr. J.E., Mannion J.D., Morrison R.C., Chung W., Fard A., et al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 95 (1997) 2684-2693
15. Faggin E., Puato M., Zardo L., Franch R., Millino C., Sarinella F., et al. Smooth muscle-specific SM22 protein is expressed in the adventitial cells of balloon-injured rabbit carotid artery. Arterioscler Thromb Vasc Biol 19 (1999) 1393-1404
16. Li G., Chen S.J., Oparil S., Chen Y.F., and Thompson J.A. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 101 (2000) 1362-1365
17. Sata M. Molecular strategies to treat vascular diseases: circulating vascular progenitor cell as a potential target for prophylactic treatment of atherosclerosis. Circ J 67 (2003) 983-991
18. Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 13 (2003) 249-253
19. Margariti A., Zeng L., and Xu Q. Stem cells, vascular smooth muscle cells and atherosclerosis. Histol Histopathol 21 (2006) 979-985
20. Yokote K., Take A., Nakaseko C., Kobayashi K., Fujimoto M., Kawamura H., et al. Bone marrow-derived vascular cells in response to injury. J Atheroscler Thromb 10 (2003) 205-210
21. Gittenberger-de Groot A.C., DeRuiter M.C., Bergwerff M., and Poelmann R.E. Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 19 (1999) 1589-1594
22. Religa P., Bojakowski K., Maksymowicz M., Bojakowska M., Sirsjo A., Gaciong Z., et al. Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation 74 (2002) 1310-1315
23. Campbell J.H., Han C.L., and Campbell G.R. Neointimal formation by circulating bone marrow cells. Ann N Y Acad Sci 947 (2001) 18-24 discussion 24-15
24. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002) 403-409
25. Shimizu K., Sugiyama S., Aikawa M., Fukumoto Y., Rabkin E., Libby P., et al. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat Med 7 (2001) 738-741
26. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84 (2004) 767-801
27. Frid M.G., Moiseeva E.P., and Stenmark K.R. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res 75 (1994) 669-681
28. Wang Z., Wang D.Z., Hockemeyer D., McAnally J., Nordheim A., and Olson E.N. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428 (2004) 185-189
29. Pipes G.C., Creemers E.E., and Olson E.N. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 20 (2006) 1545-1556
30. Campbell G.R., and Campbell J.H. The phenotypes of smooth muscle expressed in human atheroma. Ann N Y Acad Sci 598 (1990) 143-158
31. Thyberg J., Blomgren K., Hedin U., and Dryjski M. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study. Cell Tissue Res 281 (1995) 421-433
32. Reusch P., Wagdy H., Reusch R., Wilson E., and Ives H.E. Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. Circ Res 79 (1996) 1046-1053
33. Li C., Hu Y., Mayr M., and Xu Q. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways. J Biol Chem 274 (1999) 25273-25280
34. Li C., and Xu Q. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal 12 (2000) 435-445
35. Hautmann M.B., Madsen C.S., and Owens G.K. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 272 (1997) 10948-10956
36. Garat C., Van Putten V., Refaat Z.A., Dessev C., Han S.Y., and Nemenoff R.A. Induction of smooth muscle alpha-actin in vascular smooth muscle cells by arginine vasopressin is mediated by c-Jun amino-terminal kinases and p38 mitogen-activated protein kinase. J Biol Chem 275 (2000) 22537-22543
37. Hirschi K.K., Rohovsky S.A., Beck L.H., Smith S.R., and D'Amore P.A. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 84 (1999) 298-305
38. Pickering J.G. Regulation of vascular cell behavior by collagen: form is function. Circ Res 88 (2001) 458-459
39. Su B., Mitra S., Gregg H., Flavahan S., Chotani M.A., Clark K.R., et al. Redox regulation of vascular smooth muscle cell differentiation. Circ Res 89 (2001) 39-46
40. Kawai-Kowase K., and Owens G.K. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 292 (2007) C59-C69
41. Dandre F., and Owens G.K. Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am J Physiol Heart Circ Physiol 286 (2004) H2042-H2051
42. Li X., Van Putten V., Zarinetchi F., Nicks M.E., Thaler S., Heasley L.E., et al. Suppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2. Biochem J 327 (1997) 709-716
43. Van Putten V., Li X., Maselli J., and Nemenoff R.A. Regulation of smooth muscle alpha-actin promoter by vasopressin and platelet-derived growth factor in rat aortic vascular smooth muscle cells. Circ Res 75 (1994) 1126-1130
44. Holycross B.J., Blank R.S., Thompson M.M., Peach M.J., and Owens G.K. Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res 71 (1992) 1525-1532
45. Blank R.S., and Owens G.K. Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J Cell Physiol 142 (1990) 635-642
46. Corjay M.H., Blank R.S., and Owens G.K. Platelet-derived growth factor-induced destabilization of smooth muscle alpha-actin mRNA. J Cell Physiol 145 (1990) 391-397
47. Liu Y., Sinha S., McDonald O.G., Shang Y., Hoofnagle M.H., and Owens G.K. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 280 (2005) 9719-9727
48. McDonald O.G., Wamhoff B.R., Hoofnagle M.H., and Owens G.K. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest 116 (2006) 36-48
49. Hayashi K., Shibata K., Morita T., Iwasaki K., Watanabe M., and Sobue K. Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J Biol Chem 279 (2004) 40807-40818
50. Hayashi K., Takahashi M., Kimura K., Nishida W., Saga H., and Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol 145 (1999) 727-740
51. Wang J., Niu W., Nikiforov Y., Naito S., Chernausek S., Witte D., et al. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest 100 (1997) 1425-1439
52. Grant M.B., Wargovich T.J., Ellis E.A., Caballero S., Mansour M., and Pepine C.J. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis?. Circulation 89 (1994) 1511-1517
53. Cercek B., Fishbein M.C., Forrester J.S., Helfant R.H., and Fagin J.A. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res 66 (1990) 1755-1760
54. Bornfeldt K.E., Arnqvist H.J., and Capron L. In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus insulin-like growth factor I and insulin. Diabetologia 35 (1992) 104-108
55. Lieskovska J., Ling Y., Badley-Clarke J., and Clemmons D.R. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. J Biol Chem 281 (2006) 25041-25053
56. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
57. Yamashita A., Hanna A.K., Hirata S., Dardik A., and Sumpio B.E. Antisense basic fibroblast growth factor alters the time course of mitogen-activated protein kinase in arterialized vein graft remodeling. J Vasc Surg 37 (2003) 866-873
58. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
59. Facchiano A., De Marchis F., Turchetti E., Facchiano F., Guglielmi M., Denaro A., et al. The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor. J Cell Sci 113 (2000) 2855-2863
60. Igura T., Kawata S., Miyagawa J., Inui Y., Tamura S., Fukuda K., et al. Expression of heparin-binding epidermal growth factor-like growth factor in neointimal cells induced by balloon injury in rat carotid arteries. Arterioscler Thromb Vasc Biol 16 (1996) 1524-1531
61. Nakano T., Raines E.W., Abraham J.A., Wenzel F.Gt., Higashiyama S., Klagsbrun M., et al. Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor-like growth factor in human aortic smooth muscle cells. J Biol Chem 268 (1993) 22941-22947
62. Dardik A., Yamashita A., Aziz F., Asada H., and Sumpio B.E. Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha. J Vasc Surg 41 (2005) 321-331
63. Asada H., Paszkowiak J., Teso D., Alvi K., Thorisson A., Frattini J.C., et al. Sustained orbital shear stress stimulates smooth muscle cell proliferation via the extracellular signal-regulated protein kinase 1/2 pathway. J Vasc Surg 42 (2005) 772-780
64. Bornfeldt K.E., and Krebs E.G. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal 11 (1999) 465-477
65. Seger R., and Krebs E.G. The MAPK signaling cascade. Faseb J 9 (1995) 726-735
66. Servant M.J., Giasson E., and Meloche S. Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem 271 (1996) 16047-16052
67. Bornfeldt K.E., Campbell J.S., Koyama H., Argast G.M., Leslie C.C., Raines E.W., et al. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets. J Clin Invest 100 (1997) 875-885
68. Nelson P.R., Yamamura S., Mureebe L., Itoh H., and Kent K.C. Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase. J Vasc Surg 27 (1998) 117-125
69. Sturgill T.W., and Wu J. Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6. Biochim Biophys Acta 1092 (1991) 350-357
70. Nishida E., and Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18 (1993) 128-131
71. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
72. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8 (1996) 205-215
73. Robinson M.J., and Cobb M.H. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9 (1997) 180-186
74. Lewis T.S., Shapiro P.S., and Ahn N.G. Signal transduction through MAP kinase cascades. Adv Cancer Res 74 (1998) 49-139
75. Hunter T. Signaling--2000 and beyond. Cell 100 (2000) 113-127
76. Brazil D.P., Yang Z.Z., and Hemmings B.A. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 29 (2004) 233-242
77. Brazil D.P., Park J., and Hemmings B.A. PKB binding proteins. Getting in on the Akt. Cell 111 (2002) 293-303
78. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
79. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2 (2002) 489-501
80. Hajduch E., Litherland G.J., and Hundal H.S. Protein kinase B (PKB/Akt)--a key regulator of glucose transport?. FEBS Lett 492 (2001) 199-203
81. Shiojima I., and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90 (2002) 1243-1250
82. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 (1999) 597-601
83. Stabile E., Zhou Y.F., Saji M., Castagna M., Shou M., Kinnaird T.D., et al. Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit. Circ Res 93 (2003) 1059-1065
84. Oudit G.Y., Sun H., Kerfant B.G., Crackower M.A., Penninger J.M., and Backx P.H. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37 (2004) 449-471
85. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., and Chen C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6 (2004) 483-495
86. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8 (2005) 241-254
87. Kozai T., Eto M., Yang Z., Shimokawa H., and Luscher T.F. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway. Cardiovasc Res 68 (2005) 475-482
88. Rolfe B.E., Worth N.F., World C.J., Campbell J.H., and Campbell G.R. Rho and vascular disease. Atherosclerosis 183 (2005) 1-16
89. Worth N.F., Campbell G.R., Campbell J.H., and Rolfe B.E. Rho expression and activation in vascular smooth muscle cells. Cell Motil Cytoskeleton 59 (2004) 189-200
90. Worth N.F., Campbell G.R., and Rolfe B.E. A role for rho in smooth muscle phenotypic regulation. Ann N Y Acad Sci 947 (2001) 316-322
91. Liu Y., Suzuki Y.J., Day R.M., and Fanburg B.L. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin. Circ Res 95 (2004) 579-586
92. Shibata R., Kai H., Seki Y., Kato S., Morimatsu M., Kaibuchi K., et al. Role of Rho-associated kinase in neointima formation after vascular injury. Circulation 103 (2001) 284-289
93. Mack C.P., Somlyo A.V., Hautmann M., Somlyo A.P., and Owens G.K. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 276 (2001) 341-347
94. Clowes A.W., Clowes M.M., Fingerle J., and Reidy M.A. Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol 14 suppl 6 (1989) S12-S15
95. Schmidt A., Lorkowski S., Seidler D., Breithardt G., and Buddecke E. TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC. Eur J Clin Invest 36 (2006) 473-482
96. Casscells W. Smooth muscle cell growth factors. Prog Growth Factor Res 3 (1991) 177-206
97. Eto H., Biro S., Miyata M., Kaieda H., Obata H., Kihara T., et al. Angiotensin II type 1 receptor participates in extracellular matrix production in the late stage of remodeling after vascular injury. Cardiovasc Res 59 (2003) 200-211
98. Carreras I., Rich C.B., Panchenko M.P., and Foster J.A. Basic fibroblast growth factor decreases elastin gene transcription in aortic smooth muscle cells. J Cell Biochem 85 (2002) 592-600
99. Raines E.W. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol 81 (2000) 173-182
100. Geng Y.J., and Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 22 (2002) 1370-1380
101. Comoglio P.M., Boccaccio C., and Trusolino L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol 15 (2003) 565-571
102. Fukuhara T., Shimizu K., Kawakatsu T., Fukuyama T., Minami Y., Honda T., et al. Activation of Cdc42 by trans interactions of the cell adhesion molecules nectins through c-Src and Cdc42-GEF FRG. J Cell Biol 166 (2004) 393-405
103. Fukuyama T., Ogita H., Kawakatsu T., Fukuhara T., Yamada T., Sato T., et al. Involvement of the c-Src-Crk-C3G-Rap1 signaling in the nectin-induced activation of Cdc42 and formation of adherens junctions. J Biol Chem 280 (2005) 815-825
104. Kawakatsu T., Ogita H., Fukuhara T., Fukuyama T., Minami Y., Shimizu K., et al. Vav2 as a Rac-GDP/GTP exchange factor responsible for the nectin-induced, c-Src- and Cdc42-mediated activation of Rac. J Biol Chem 280 (2005) 4940-4947
105. Honda T., Shimizu K., Kawakatsu T., Fukuhara A., Irie K., Nakamura T., et al. Cdc42 and Rac small G proteins activated by trans-interactions of nectins are involved in activation of c-Jun N-terminal kinase, but not in association of nectins and cadherin to form adherens junctions, in fibroblasts. Genes Cells 8 (2003) 481-491
106. Caplice N.M., Bunch T.J., Stalboerger P.G., Wang S., Simper D., Miller D.V., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A 100 (2003) 4754-4759
107. Deb A., Skelding K.A., Wang S., Reeder M., Simper D., and Caplice N.M. Integrin profile and in vivo homing of human smooth muscle progenitor cells. Circulation 110 (2004) 2673-2677
108. Shin'oka T., Imai Y., and Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344 (2001) 532-533
109. Shin'oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129 (2005) 1330-1338
110. Perlman H., Maillard L., Krasinski K., and Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 95 (1997) 981-987
111. Apenberg S., Freyberg M.A., and Friedl P. Shear stress induces apoptosis in vascular smooth muscle cells via an autocrine Fas/FasL pathway. Biochem Biophys Res Commun 310 (2003) 355-359
112. Degterev A., Boyce M., and Yuan J. A decade of caspases. Oncogene 22 (2003) 8543-8567
113. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9 (2002) 459-470
114. Kronke M., and Adam-Klages S. Role of caspases in TNF-mediated regulation of cPLA(2). FEBS Lett 531 (2002) 18-22
115. Micheau O., and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 (2003) 181-190
116. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
117. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
118. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
119. Kanzaki T., Shinomiya M., Ueda S., Morisaki N., Saito Y., and Yoshida S. Enhanced arterial intimal thickening after balloon catheter injury in diabetic animals accompanied by PDGF beta-receptor overexpression of aortic media. Eur J Clin Invest 24 (1994) 377-381
120. Kawano M., Koshikawa T., Kanzaki T., Morisaki N., Saito Y., and Yoshida S. Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF beta-receptors. Eur J Clin Invest 23 (1993) 84-90
121. Kanzaki T., and Otabe M. Latent transforming growth factor-beta binding protein-1, a component of latent transforming growth factor-beta complex, accelerates the migration of aortic smooth muscle cells in diabetic rats through integrin-beta3. Diabetes 52 (2003) 824-828
122. Igarashi M., Wakasaki H., Takahara N., Ishii H., Jiang Z.Y., Yamauchi T., et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103 (1999) 185-195
123. Jacot T.A., and Clemmons D.R. Effect of glucose on insulin-like growth factor binding protein-4 proteolysis. Endocrinology 139 (1998) 44-50
124. Resch Z.T., Simari R.D., and Conover C.A. Targeted disruption of the PAPP-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia following vascular injury. Endocrinology 147 (2006) 5634-5640
125. Martinez-Lemus L.A., Wu X., Wilson E., Hill M.A., Davis G.E., Davis M.J., et al. Integrins as unique receptors for vascular control. J Vasc Res 40 (2003) 211-233
126. Zhou W., Lin P.H., Bush R.L., Peden E.K., Guerrero M.A., Kougias P., et al. Management of in-sent restenosis after carotid artery stenting in high-risk patients. J Vasc Surg 43 (2006) 305-312
127. Williams D.O., Abbott J.D., and Kip K.E. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents. Report of the DEScover Registry. Circulation 14;114 (2006) 2154-2162
128. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
129. Huang S., Shu L., Dilling M.B., Easton J., Harwood F.C., Ichijo H., et al. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol Cell 11 (2003) 1491-1501
130. Poon M., Marx S.O., Gallo R., Badimon J.J., Taubman M.B., and Marks A.R. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 98 (1996) 2277-2283
131. Hassan G.S., Williams T.M., Frank P.G., and Lisanti M.P. Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction. Am J Physiol Heart Circ Physiol 290 (2006) H2393-H2401
132. Cooney R., Hynes S.O., Sharif F., Howard L., and O'Brien T. Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury. Gene Ther 14 (2007) 396-404
133. Rekhter M.D., Simari R.D., Work C.W., Nabel G.J., Nabel E.G., and Gordon D. Gene transfer into normal and atherosclerotic human blood vessels. Circ Res 82 (1998) 1243-1252
134. Nabel E.G. Gene therapy for cardiovascular disease. Circulation 91 (1995) 541-548